Published • loading... • Updated
1,5-Pentanediamine from CRKP-colonized patients weakens CD19 CAR-T cells in
Summary by BIOENGINEER.ORG
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Scienmag: Latest Science and Health NewsReposted by 
BIOENGINEER.ORG
BIOENGINEER.ORG1,5-Pentanediamine from CRKP-colonized patients weakens CD19 CAR-T cells in
A bacterial metabolite that circulates in the blood of patients colonized with carbapenem-resistant Klebsiella pneumoniae appears to sabotage one of modern medicine’s most powerful cancer therapies, according to a new study published in Cancer Immunology, Immunotherapy. Researchers at Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, report that 1,5-pentanediamine—better known by […]
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
